Skip to main content

The promotion to AMX further validates Pharming’s strong growth and the success of the Company’s commercialisation platform, as well as providing access to a new pool of funds mandated to invest in companies in this index.

- Sijmen de Vries - CEO
Cookies: This website uses cookies Check the cookies page for more information Accept Decline